Novo Nordisk (NOVOB DC) says Wegovy (Semaglutide 7.2mg) has been approved in the US, providing 20.7% mean weight loss
Every headline is on the live feed 20 minutes before this site.
US President Trump says will discuss trade and other things with Japanese PM
The White House will not implement a crude export ban, and told oil executives as much at this morning’s meeting with API, Politico reports, citing a source
Novo Nordisk (NOVOB DC) says Wegovy (Semaglutide 7.2mg) has been approved in the US, providing 20.7% mean weight loss
US State Department approves possible foreign military sale to Jordan of aircraft and munitions support and related equipment; approves potential sale of fixed site - low, slow, small unmanned aircraft integrated defeat system to UAE for USD 2.1bln
The White House has discussed adding up to 100mln more barrels to the administration’s pledge last week, Politico reports, citing sources
On the Newsquawk feed at , 20 minutes before this page.
Context
Novo Nordisk's approval of Wegovy in the US is significant as it reinforces its position in the obesity treatment market, with a reported mean weight loss of 20.7%. This news could positively influence investor sentiment and lead to upward pressure on its stock, particularly given the growing demand for effective weight management solutions. Observers should also consider potential implications for healthcare expenditure and upcoming competitive dynamics in the sector.
Related headlines
- Weekly US Earnings Estimates: 19th-23rd October 2026: Earnings pick up with META, TSLA, SPCX, LRCX, and NFLX the highlights17 hours ago
- Nvidia (NVDA) expands tools for building AI-powered games with Unreal Engine 518 hours ago
- US FAA is set to approve certification for the Boeing (BA) 737 MAX 10, sources report; potentially as soon as in the next week19 hours ago
- Daily US Earnings Estimates: 19th October 2026: FITB, WRB, and STLD20 hours ago
- T-Mobile (TMUS) downside attributed to a terminated relationship with SpaceX (SPCX) - UNCONFIRMED21 hours ago
- Michael Dell (DELL) expects memory crunch to get worse, WSJ reports21 hours ago
- US officials pressed Beijing on market access issues for Mastercard (MA) and Citigroup (C) during at least two bilateral meetings with Chinese counterparts in Bangkok this week, CNBC reports, citing a source21 hours ago
- Apple (AAPL) set for UK legal fight over iPhone tap-to-pay rules, FT reports22 hours ago
- US EQUITY OPEN: Stocks mixed at the open as AI stock rout continues23 hours ago
- US DoJ officials have reportedly signalled their preference to settle antitrust lawsuit against Apple (AAPL), The Information reports citing sources1 day ago
- Daily US Equity Opening News: 16th October 2026: TSLA gains on Roadster reveal; NFLX slips as Content Chief to leave; TRV earnings underwhelm1 day ago
- US PREMARKET MOVERS: TSLA, NFLX, VRNS, AA, TRV, MSTR, WDAY, ECHO1 day ago
- Charles Schwab (SCHW) CEO says seeing record levels of interest in fixed income; Brokerage is blocking unauthorised AI agents1 day ago
- Apple (AAPL) iPhone duo delivery date slips to January 25th1 day ago
- US BROKER MOVES: CPRI upgrade at Raymond James; WDAY downgraded at KeyBanc1 day ago
- Apple's (AAPL) iPhone Duo sells out minutes after pre-orders open, according to Apple Insider1 day ago
- ExxonMobil (XOM) says changes in margins to impact Q3 chemical products earnings by USD -0.6bln Q/Q1 day ago
- Marqeta (MQ) and Coinbase (COIN) to enable stablecoin-backed card payments1 day ago
- Nvidia's (NVDA) RTX Spark laptops have launched globally, starting at USD 2,5991 day ago
- Travelers (TRV) Q3 2026 (USD): Adj. EPS 9.18 (exp. 7.39), Revenue 12.4bln (exp. 11.4bln); Net Premiums Written 11.48bln (exp. 11.40bln), Catastrophe Loss 538mln (exp. 695mln)1 day ago
The feed had this first.
Use the Platform